Trevi Therapeutics TRVI Earnings Call Transcripts

NASDAQ TRVI
$14.91 -0.40 (-2.61%)
At close: Nov 10, 2026 · 4:00 PM EST
1 earnings call on file for Trevi Therapeutics, Q4 2025. Each transcript opens in a new tab.
Latest earnings call

Trevi Therapeutics Q4 2025 Earnings Call

Mar 17, 2026 7,047 words · 31 min read
  • Jennifer GoodChief Executive Officer
  • James CassellaChief Development Officer
  • Farrell SimonChief Commercial Officer
  • David HastingsChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Trevi Therapeutics Earnings Call Transcripts

Calls1
LatestMar 17, 2026
SinceQ4 2025

Fiscal 2025

All 1 Trevi Therapeutics transcript Register to get access to Trevi Therapeutics’s earnings call transcripts.